March 21, 2022
PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
NOT-TR-22-026 Notice of Change in Funding Opportunity Description and Application and Submission Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform potential applicants of the changes in the Award Information for PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional). These changes are in response to Congressional report language in the Joint Explanatory Statement for the Consolidated Appropriations Act, 2022.
Section II. Award Information
Award Budget
Currently Reads:
Award Budget
The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:
|
Size Eligibility Budget Tiers for FOA Applicants |
Maximum Direct Cost Budget Requests for UM1 |
|
|
Hub Tier |
5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current Total Cost (TC) NIH funding in Clinical Research category of any partner(s)* (based on FY2016-FY2020 NIH Funding data) |
UM1 |
|
A |
>$250,000,000 |
$6,500,000 |
|
C |
$250,000,000 - $200,000,000 |
$5,000,000 |
|
T |
$199,999,999 - $125,000,000 |
$3,600,000 |
|
G |
<$125,000,000 |
$2,600,000 |
Revised to Read:
Award Budget
The amount of funding that applicants can request depends on the amount of NIH funding they receive. After calculating the total amount of NIH funding received as described in Section IV. Application and Submission Information, 2. Content and Form of Application Submission, R&R Budget, applicants may request the following amounts:
|
Size Eligibility Budget Tiers for FOA Applicants |
Maximum Direct Cost Budget Requests for UM1 |
|
|
Hub Tier |
5-year average of the most current NIH Direct Cost (DC) Funding of the applicant institution, PLUS 5-year average of the most current NIH Direct Cost (DC) funding of any partner(s)* (based on FY2016-FY2020 NIH Funding data) |
UM1 |
|
A |
>$300,000,000 |
$6,500,000 |
|
C |
$220,000,000 - $300,000,000 |
$5,000,000 |
|
T |
$135,000,000 - $219,999,999 |
$3,600,000 |
|
G |
<$135,000,000 |
$2,600,000 |
All other aspects of the Funding Opportunity Announcement remain unchanged.
Erica Rosemond, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-594-8927
Email: [email protected]
and Human Services (HHS)
